These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
221 related items for PubMed ID: 23179473
1. Real-world treatment of post-herpetic neuralgia with gabapentin or pregabalin. Johnson P, Becker L, Halpern R, Sweeney M. Clin Drug Investig; 2013 Jan; 33(1):35-44. PubMed ID: 23179473 [Abstract] [Full Text] [Related]
2. Comparing healthcare costs of Medicaid patients with postherpetic neuralgia (PHN) treated with lidocaine patch 5% versus gabapentin or pregabalin. Kirson NY, Ivanova JI, Birnbaum HG, Wei R, Kantor E, Puenpatom RA, Ben-Joseph RH, Summers KH. J Med Econ; 2010 Jan; 13(3):482-91. PubMed ID: 20684669 [Abstract] [Full Text] [Related]
3. A retrospective evaluation of the use of gabapentin and pregabalin in patients with postherpetic neuralgia in usual-care settings. Gore M, Sadosky A, Tai KS, Stacey B. Clin Ther; 2007 Aug; 29(8):1655-70. PubMed ID: 17919547 [Abstract] [Full Text] [Related]
5. Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective. Tarride JE, Gordon A, Vera-Llonch M, Dukes E, Rousseau C. Clin Ther; 2006 Nov; 28(11):1922-34. PubMed ID: 17213013 [Abstract] [Full Text] [Related]
6. Pregabalin versus gabapentin in the management of peripheral neuropathic pain associated with post-herpetic neuralgia and diabetic neuropathy: a cost effectiveness analysis for the Greek healthcare setting. Athanasakis K, Petrakis I, Karampli E, Vitsou E, Lyras L, Kyriopoulos J. BMC Neurol; 2013 Jun 04; 13():56. PubMed ID: 23731598 [Abstract] [Full Text] [Related]
12. Costs of pregabalin or gabapentin for painful diabetic peripheral neuropathy. Udall M, Harnett J, Mardekian J. J Med Econ; 2012 Jun 04; 15(2):361-70. PubMed ID: 22181052 [Abstract] [Full Text] [Related]
13. Replacement of gabapentin with pregabalin in postherpetic neuralgia therapy. Ifuku M, Iseki M, Hidaka I, Morita Y, Komatus S, Inada E. Pain Med; 2011 Jul 04; 12(7):1112-6. PubMed ID: 21692969 [Abstract] [Full Text] [Related]
14. Efficacy of low dose gabapentin in acute herpes zoster for preventing postherpetic neuralgia: a prospective controlled study. Lee EG, Lee HJ, Hyun DJ, Min K, Kim DH, Yoon MS. Dermatol Ther; 2016 May 04; 29(3):184-90. PubMed ID: 26799145 [Abstract] [Full Text] [Related]
15. Costs and health resources utilization following switching to pregabalin in individuals with gabapentin-refractory neuropathic pain: a post hoc analysis. Navarro A, Saldaña MT, Pérez C, Masramón X, Rejas J. Pain Pract; 2012 Jun 04; 12(5):382-93. PubMed ID: 22004531 [Abstract] [Full Text] [Related]
16. A comparison of pregabalin and gabapentin in palliative care #289. Pruskowski J, Arnold RM. J Palliat Med; 2015 Apr 04; 18(4):386-7. PubMed ID: 25714108 [No Abstract] [Full Text] [Related]
18. Cost comparison of adding pregabalin or gabapentin for the first time to the therapy of patients with painful axial radiculopathy treated in Spain. Sicras-Mainar A, Rejas-Gutiérrez J, Navarro-Artieda R, Planas-Comes A. Clin Exp Rheumatol; 2013 Apr 04; 31(3):372-81. PubMed ID: 23432967 [Abstract] [Full Text] [Related]
19. Adding pregabalin or gabapentin for the management of community-treated patients with painful diabetic peripheral neuropathy: a comparative cost analysis. Sicras A, Rejas J, Navarro R, Planas A. Clin Drug Investig; 2013 Nov 04; 33(11):825-35. PubMed ID: 24085589 [Abstract] [Full Text] [Related]
20. Safety and efficacy of once-daily gastroretentive gabapentin in patients with postherpetic neuralgia aged 75 years and over. Gupta A, Li S. Drugs Aging; 2013 Dec 04; 30(12):999-1008. PubMed ID: 24163280 [Abstract] [Full Text] [Related] Page: [Next] [New Search]